1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   Response -  Analytic Code
   
   
3. Who will be able to view these files?
   Response - Researchers who provide a methodologically sound proposal.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Data are available indefinitely at (Link to be included Nil).
   


6. For how long will this data be available start date provided 01-12-2026 and end date provided 01-01-2035?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - nil

BPPV is characterized by vertigo lasting for seconds associated with balancing problem, nystagmus, nausea and vomiting. It is the most common cause of vertigo worldwide with a prevalence of  10.7 - 140/100,000.Though it is a benign condition, 60 % of patients with BPPV require leave from work, 86 % experience interruption to activities of daily living, 38 % of patients fall down as a direct consequence, with incidence of both BPPV and falls increasing with increasing age.

Treatment recommendation include Canalith repositioning procedure(CRP), vestibular suppression medications and rehabilitative exercises. Despite the success of CRP showing odds ratio of 4.2 in resolution of symptoms 20% of BPPV doesnot benefit from it and shows mild negative outcomes. Vestibular medications are also not advised for long as it produces drowsiness, Cognitive deficits , Interference with driving vehicles or operating machineries. Datas are also not available showing widely accepted interval regarding CRP.

Reviewing the classics the symptoms of BPPV can be correlated to bhrama where a person feels that everything around him is spinning like a wheel “chakravat bhramana” caused due to the vitiation of pitta and vata with involvement of raja. Line of treatment can be according to doshapratyaneekata and its site of manifestation. In the present study kalyanaka grita nasya is chosen. Drakshadi kashaya and eladi vati  selected for internal administration is vatapittahara tridoshahara respectively and both are advised to be effective in bhrama.

Hence the present study is to assess whether Kalyanaka grita nasya, Drakshadi kashaya, Eladi vati with Epley’s Maneuver is more effective than Epley’s Maneuver alone in the management of BPPV. The clinical study will be carried out in 30 patients with BPPV who fulfil inclusion criteria belonging to either sex from OPD and IPD of Amrita School of Ayurveda. VSS- sf, DHI questionnaire and Dix Hallpike test will be assessed. Patient will be allocated into Group A and B. Consent will be taken in their own language before treatment, subjective parameters will be assessed and recorded in CRF. Group A will be given 4ml Kalyanaka grita marsha nasya, Drakshadi kashaya and eladi vati along with Epleys manuever and group B with  Epley’s maneuver alone for 30 days. After treatment subjective parameters will be assessed, also in the 4 followup on 45^th,60^th,75^th ,90^th day to assess the sustained effect of treatment . The data obtained will be tabulated and statistically analysed using Wilcoxon signed rank test.